Potential of the Histoculture Drug-Response Assay to Contribute to Cancer Patient Survival

Clinical Cancer Research

Volumn 1, Issue 12, 1995, Pages 1537-1543

  Kubota, Tetsuro ^a,j   Sasano, Nobuaki ^h   Abe, Osahiko ^b   Nakao, Isao ⁱ   Kawamura, Eiji ^c   Saito, Tatsuo ^d   Endo, Mitsuo ^e   Kimura, Kosaburo ^f   Demura, Hiroshi ^g   Sasano, Hironobu ^h   Nagura, Hiroshi ^h   Ogawa, Nobuya ^a,j   Hoffman, Robert M ^k  

^a KEIO UNIVERSITY   (Japan)

^b ST LUKE'S INTERNATIONAL HOSPITAL   (Japan)

^c KITASATO INSTITUTE HOSPITAL   (Japan)

^d Kyoundo Hospital   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^f TOKYO MEDICAL UNIVERSITY   (Japan)

^g TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^h TOHOKU UNIVERSITY   (Japan)

ⁱ Shirakawa Hospital   (Japan)

^j EHIME UNIVERSITY   (Japan)

^k ANTICANCER INC   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

MITOMYCIN C; UFT;

ADULT; AGED; ARTICLE; ASSAY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; FEMALE; HUMAN; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; STOMACH CANCER; SURVIVAL; TISSUE CULTURE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL RATE; TEGAFUR; TUMOR STEM CELL ASSAY; URACIL;

EID: 0029620911     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Vescio, R. A., Connors, K. M., Kubota, T., and Hoffman, R. M. Correlation of histology and drug response of human tumors grown in native-state three-dimensional histoculture and in nude mice. Proc. Natl. Acad. Sci. USA, 88: 5163–5166, 1991.
2. Furukawa, T., Kubota, T., Watanabe, M., Takahara, T., Yamaguchi, H., Takeuchi, T., Kase, S., Kodaira, S., Ishibiki, K., Kitajima, M., and Hoffman, R. M. High in vitro-in vivo correlation of drug response using sponge-gel-supported three-dimensional histoculture and the MTT end point. Int. J. Cancer, 51: 489–498, 1992.
3. Furukawa, T., Kubota, T., Watanabe, M., Kase, S., Takahara, T., Yamaguchi, H., Takeuchi, T., Teramoto, T., Ishibiki, K., Kitajima, M., and Hoffman, R. M. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point. Anticancer Res., 12: 1377–1382, 1992.
4. Vescio, R. A., Redfem, C. H., Nelson, T. J., Ugoretz, S., Stern, P. H., and Hoffman, R. M. In vivo-like drug responses of human tumors growing in three-dimensional, gel-supported primary culture. Proc. Natl. Acad. Sci. USA, 84: 5029–5033, 1987.
5. Leighton, J. A sponge matrix-method for tissue culture. Formation of organized aggregates of cells in vitro. J. Natl. Cancer Inst., 12: 545–561, 1951.
6. Hoffman, R. M. In vitro sensitivity assays in cancer: a review, analysis and prognosis. J. Clin. Lab. Anal., 5: 133–143, 1991.
7. Hoffman, R. M. In vitro assays for chemotherapy sensitivity. Crit. Rev. Oncol. Hematol., 15: 99–111, 1993.
8. Hoffman, R. M. To do tissue culture in two or three dimensions? That is the question. Stern Cells, 11: 105–111, 1993.
9. Furukawa, T., Kubota, T., and Hoffman, R. M. The clinical applications of the histoculture drug response assay. Clin. Cancer Res., 1: 305–311, 1995.
10. Kubota, T., Suto, A., Ishibiki, K., Abe, O., Yamada, Y., Asanuma, F., Kawamura, E., Yamada, T., Suzuki, Y., and Suzuki, T. MTT assay using fresh surgical specimens with reference to the transfer system and reproducibility in “test center” method. Jpn. J. Cancer Chemother., 17: 2025–2030, 1990 (in Japanese with English abstract).
11. Marunaka, T., Umeno, Y., Yoshida, K., Nagamachi, M., Minami, Y., and Fujii, S. High-pressure liquid chromatography determination of Ftorafur [1-(tetrahydro-2-furanyl)-5-fluorouracil] and GLC-mass spectrometric determination of 5-fluorouracil and uracil in biological materials after ota administration of uracil plus ftorafur. J. Pharm. Sci., 69: 1296–1300, 1980.
12. Japanese Research Society for Gastric Cancer and Miwa Registryinstitute for Stomach Cancer. The Report of Treatment Results of Stomach Cancer in Japan (1982), Tokyo: Japanese Research Society for Gastric Cancer and Miwa Registry-Institute for Stomach Cancer, 1995 (in Japanese).
13. Japanese Research Society for Gastric Cancer. The General Rules for Gastric Cancer Study. Ed. 11. Tokyo: Kanehara Shuppan. 1985 (in Japanese).
14. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457–481. 1958.
15. Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., MaPherson, K., Peto, J., and Smith, P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patients, II. Analysis and examples. Br. J. Cancer, 35: 1–39, 1977.
16. Tukey, J. W. Some thoughts on clinical trials. Especially problems of multiplicity. Science (Washington DC), 198: 679–684, 1977.
17. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. Series B, 34: 187–220, 1972.
18. Chabner, B. Pharmacologic Principles of Cancer Treatment. Philadelphia: W. B. Saunders, 1982.
19. Comis, R. I., and Carter, S. K. Integration of chemotherapy into combined modality treatment of solid tumors. III. Gastric cancer. Cancer Treat. Rev., 1: 221–238, 1974.
20. Baum, M. Clinics in Oncology, Vol. 1, pp. 649–660. London: W. B. Saunders, 1982.
21. Hattori, T., Mori, A., Hirata, K., and Ito, I. Five-year survival rate of gastric cancer patients treated with gastrectomy, large dose of mitomycin-C and/or allogenic bone marrow transplantation. Gann (Jpn. J. Cancer Res.) 63: 517–522, 1972.
22. Maehara, Y., Watanabe, A., Kakeji, Y., Baba, H., Kohnoe S., and Sugimachi, K. Postoperative prescription of mitomycin C and UFT for patients with stage IV gastric carcinoma. Am. J. Surg., 160: 242–244, 1990.
23. Sadee, W., and Sayed, Y. M. E. Mechanism of Metabolie Activation of Therapy, pp. 3–11. Amsterdam: Excerpta Medica, 1984.
24. Saikawa, Y., Kubota, T., Furukawa, T., Suto, A., Watanabe, M., Kumai, K., Ishibiki, K., and Kitajima, M. Single-cell Suspension assay with an MTT end point is useful for evaluating the optimal adjuvant chemotherapy for advanced gastric cancer. Jpn. J. Cancer Res., 85: 762–765, 1994.